Innovations in Drug-Loaded Contact Lenses

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".

Deadline for manuscript submissions: closed (31 May 2024) | Viewed by 221

Special Issue Editors


E-Mail Website
Guest Editor
Department of Pharmaceutical Technology, Faculty of Pharmacy, Universidad de Santiago de Compostela, 15782 Santiago de Compostela, Spain
Interests: ocular drug delivery
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Pharmaceutical Technology, Faculty of Pharmacy, Universidad de Santiago de Compostela, 15782 Santiago de Compostela, Spain
Interests: drug delivery systems; ocular drug delivery; ocular pharmacokinetic; drug development; cyclodextrins; nanotechnology

Special Issue Information

Dear Colleagues,

Topical ophthalmic administration is the preferred route for treating ophthalmic diseases. However, due to the complexity of the structure of the eye and its defense mechanisms, the bioavailability of topical ophthalmic drugs is significantly low.

Drug-loaded contact lenses are an interesting resource to improve ocular bioavailability as they allow the prolonged release of the drug from the lens to the tear film by increasing the retention time on the ocular surface. The main disadvantage of drug-loaded contact lenses is the low affinity of some drugs that implies a low charge capacity and rapid drug release. Alternatives to improve their behavior are being studied.

The aim of this Special Issue is to compile information on recent advances in the development, processing, and characterization of drug-loaded contact lenses.

Prof. Dr. Francisco Javier Otero-Espinar
Dr. Victoria Díaz-Tomé
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • contact lenses
  • ocular drug delivery
  • ophthalmic diseases
  • therapeutic contact lens
  • advanced ocular drug delivery

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop